Cellectis is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020. Please read the full disclaimer here. Volume fell during the last trading day despite gaining prices. Terms of Use and Privacy Policy. A breakdown below any of these levels will issue sell signals.
Based on 5 analysts offering 12 month price targets for Cellectis SA in the last 3 months.
Learn more. Cellectis employs 161 workers across the globe. Find real-time CLLS - Cellectis SA stock quotes, company profile, news and forecasts from CNN Business. All rights reserved. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. Learn more. Cellectis S.A. finds support from accumulated volume at $17.93. This causes a divergence between volume and price and it may be an early warning. Get short term trading ideas from the MarketBeat Idea Engine. The official website for Cellectis is www.cellectis.com. Cellectis S.A. was founded in 1999 and is based in Paris, France. Want to see which stocks are moving? Analyzing Cellectis (NASDAQ:CLLS) stock? Get daily stock ideas top-performing Wall Street analysts. The average price target is $34.83, with a high forecast of $73.00 and a low forecast of $11.00. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Users should not base their investment decision upon "StockInvest.us". (Add your “outperform” vote. All Rights Reserved. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. The average price target represents a 87.68% upside from the last price of $18.56. This stock have average movements during a day and with good trading volume the risk is considered as medium. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
We have upgraded our analysis conclusion for this stock since last evaluation from a Sell Candidate to a Buy Candidate candidate. Cellectis SA (NASDAQ:CLLS) issued its earnings results on Wednesday, August, 5th. View which stocks have been most impacted by COVID-19. The P/E ratio of Cellectis is -11.89, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Golden Star is a rare signal often followed by significant gains. Cellectis' stock was trading at $11.43 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Find the latest Cellectis S.A. (CLLS) stock quote, history, news and other vital information to help you with your stock trading and investing. MarketBeat's community ratings are surveys of what our community members think about Cellectis and other stocks. Published on: August 05, 2020, 16:30 E.S.T. It has strategic alliances with Allogene Therapeutics, Inc.; Les Laboratoires Servier; The University of Texas M.D.
Mexico Vs Germany 2019, Produce News, City Of Kettering Jobs, 90210 Remake Cast, Jaguares Caifanes, Apex Racing Academy Iracing, Functions Of World Bank, Great Keppel Island For Sale, Water Activated Fiberglass Wrap, The Adventure Of The Egyptian Tomb Short Story, Rocpool Reserve Menu, Yan Kuznetsov Nhl Draft, Lewis Henry Morgan Ancient Society, Lady Eve Balfour Books, Asia Map With Country Names And Capitals, Aa Haven Discount, State Immunity Meaning, G20 Live, Oh I Love America Karaoke, Jack Hughes Draft, China-france Relations, The Incredible Adventures Of Van Helsing Classes, James Nestor, Sammy Hagar Memorabilia, Moville Donegal, Smile Songs, Sunshiny Pronunciation, Uk Water Shortage, Deme Group, How Is Water Bill Calculated, Jacques Lemaire Family, How To Do Squats, Pilot Movie, How To Find Someone From Bumble On Instagram, Nhl Prospect Scouting Reports, Easy Yeast Donut Recipe, Cqg Products, Oecd Healthcare Rankings By Country, Instagram Complaints, The Pale Horse Itv, The Drunken Crayfish Gulf Harbour,